3 Reasons to Buy Moderna Stock
Although (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in the COVID-19 vaccine market catapulted it to new heights.
However, once the pandemic began subsiding, with a substantial decline in coronavirus-related sales, Moderna's shares suffered. They're down by 25% over the past three years. Is Moderna just a pandemic stock?
Not at all. Let's consider three reasons why investing in the company today is worth it.
Source Fool.com
Moderna Inc. Aktie
54,72 €
-1,09 %
Leichtes Kaufinteresse bei Moderna Inc., mit mehr Buy- als Sell-Einschätzungen.
Ein negatives Potenzial von -61.62% für Moderna Inc., selbst mit einem niedrigeren Kursziel von 21 € als 54.72 €.
